| 注册
首页|期刊导航|中国伤残医学|康柏西普玻璃体腔注射联合小梁切除术及视网膜光凝治疗新生血管性青光眼临床观察

康柏西普玻璃体腔注射联合小梁切除术及视网膜光凝治疗新生血管性青光眼临床观察

郭振山 乌云

中国伤残医学Issue(7):23-25,3.
中国伤残医学Issue(7):23-25,3.DOI:10.13214/j.cnki.cjotadm.2015.07.013

康柏西普玻璃体腔注射联合小梁切除术及视网膜光凝治疗新生血管性青光眼临床观察

The Clinical Observation of Intravitreal Injection of Conbercept Combined with Trabeculectomy and Retinal Photocoagulation for the Treatment of Neovascular Glaucoma

郭振山 1乌云1

作者信息

  • 1. 呼伦贝尔市人民医院眼科,内蒙古呼伦贝尔 021008
  • 折叠

摘要

Abstract

Objective:To observe the clinical effect of intravitreal injection of Conbercept combined with trabeculectomy and retinal photocoagulation for the treatment of neovascular glaucoma ( NVG) .Methods:14 cases (14 eyes) of NVG were managed with intravitreal Conbercept combined with trabeculectomy (5-7 days after injection),and then treated the primary disease by retinal photocoagulation. Results:Follow-up 3~6 months,iris neovascularization was disappeared in all the cases,and the average intraocular pressures ( IOP) were 20.29 ±3.69mmHg, which had significant difference compared with preoperative IOP(57.71 ±7.17 mmHg)(P<0.05).No serious complications occurred in the process of treatment,and the safety was satisfactory.Conclusion:Intravitreal injection of Conbercept com-bined with trabeculectomy and retinal photocoagulation is safe and effective for the treatment of NVG.

关键词

康柏西普/小梁切除术/视网膜光凝/新生血管性青光眼

Key words

Conbercept/Trabeculectomy/Retinal photocoagulation/Neovascular glaucoma

分类

医药卫生

引用本文复制引用

郭振山,乌云..康柏西普玻璃体腔注射联合小梁切除术及视网膜光凝治疗新生血管性青光眼临床观察[J].中国伤残医学,2015,(7):23-25,3.

中国伤残医学

1673-6567

访问量0
|
下载量0
段落导航相关论文